Abstract
Atherosclerosis occurs more often and at an earlier age in diabetics than in non-diabetics. A possible explanation for this is that risk factors for atherosclerosis in the general population are more common in diabetics. This chapter discusses the prevalence of cardiovascular risk factors in diabetes and their relationship to atherosclerosis in diabetics. Some characteristics of diabetes itself will also be discussed. Abnormalities of lipid metabolism in diabetes are the subject of another chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garcia, M. J., McNamara, P. M., Gordon, T. and Kannel, W. B. (1974). Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes, 23, 105
Kannel, W. B. and McGee, D. L. (1979). Diabetes and cardiovascular disease. The Framingham study. J. Am. Med. Assoc., 241, 2035
Kannel, W. B. and Dawber, T. R. (1974). Hypertension as an ingredient of a cardiovascular risk profile. Br. J. Hosp. Med., 11, 508
Veterans Administration Co-operative Study Group on Anti-hypertensive Agents (1967). Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. J. Am. Med. Assoc., 202, 1028
Veterans Administration Co-operative Study Group on Anti-hypertensive Agents (1970). Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. J. Am. Med. Assoc., 213, 1143
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. and Dawber, T. R. (1977). Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann. Intern. Med., 87, 393
Medalie, J. H., Papier, C. M., Goldbourt, U. and Herman, J. B. (1975). Major factors in the development of diabetes mellitus in 10000 men. Arch. Intern. Med., 135, 811
Ostrander, L. D., Francis, T., Hayner, N. S., Kjelsberg, M. O. and Epstein, F. H. (1965). The relationship of cardiovascular disease to hyperglycemia. Arch. Intern. Med., 62, 1188
Pell, S. and D’Alonzo, C. A. (1967). Some aspects of hypertension in diabetes mellitus. J. Am. Med. Assoc., 202, 10
Keen, H., Track, N. S. and Sowry, G. S. C. (1975). Arterial pressure in clinically apparent diabetics. Diabete Metab., 1, 159
Kannel, W. B. and McGee, D. L. (1979). Diabetes and cardiovascular risk factors: the Framingham study. Circulation, 59, 8
Pell, S. and D’Alonzo, C. A. (1970). Factors associated with long-term survival of diabetes. J. Am. Med. Assoc., 214, 1833
Ostrander, L. D., Lamphiear, D. E., Carman, W. J. and Williams, G. W. (1981). Blood glucose and risk of coronary disease. Arteriosclerosis, 1, 33
Goodkin, G. (1975). Mortality factors in diabetes. A 20 year mortality study. J. Occup. Med., 17, 716
Jarrett, R. J., Keen, H., Fuller, J. H. and McCartney, M. (1977). Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin. Br. Med. J., 2, 861
Fuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J. and Keen, H. (1980). Coronary- heart-disease risk and impaired glucose tolerance. Lancet, 1, 1373
Gordon, T. and Kannel, W. B. (1972). Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. J. Am. Med. Assoc., 221, 661
Armstrong, B. and Doll, R. (1975) Bladder cancer mortality in diabetics in, relation to saccharin consumption and smoking habits. Br. J. Prev. Soc. Med., 29, 73
Czyzyk, A. and Krolewski, A. S. (1976). Is cigarette smoking more frequent among insulin treated diabetics? Diabetes, 25, 717
Pyke, D. A. and Please, N. W. (1957). Obesity, parity and diabetes. J. Endocrinol., 15, xxvi
Reinheimer, W., Bliffen, G., McCoy, J., Wallace, D. and Albrink, M. J. (1967). Weight gain, serum lipids and vascular disease in diabetics. Am. J. Clin. Nutr., 20, 986
Santen, R. J., Willis, P. W. and Fajans, S. S. (1972). Atherosclerosis in diabetes mellitus. Arch. Intern. Med., 130, 833
Bagdade, J. D., Bierman, E. L. and Porte, D. Jr. (1971). Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia. Diabetes, 20, 664
Montoye, H. J., Epstein, F. H. and Kjelsberg, M. O. (1966). Relationship between serum cholesterol and body fatness, an epidemiological study. Am. J. Clin. Nutr., 18, 397
Nestel, P. J., Whyte, H. M. and Goodman, D. S. (1969). Distribution and turnover of cholesterol in humans. J. Clin. Invest., 48, 982
Miettinen, T. A. (1971). Cholesterol production in obesity. Circulation, 44, 842
Kannel, W. B., Brand, N., Skinner, J. J., Dawber, T. R. and McNamara, P. M. (1967). The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann. Intern. Med., 67, 48
Chiang, B. N., Perlman, L. V. and Epstein, F. H. (1969). Overweight and hypertension. Circulation, 39, 403
Bierman, E. L. (1979). Carbohydrate and sucrose intake in the causation of atherosclerotic heart disease, diabetes mellitus and dental caries. Am. J. Clin. Nutr., 32, 2644
Medalie, J. H., Papier, C., Herman, J. B. et al. (1974). Diabetes mellitus among 10,000 adult men. I. Five year incidence and associated variables. Israel j. Med. Sci., 10, 681
Ahrens, E. H. (1979). Dietary fats and coronary heart disease: unfinished business. Lancet, 2, 1345
Albrink, M. J., Lavietes, P. H. and Man, E. B. (1963). Vascular disease and serum lipids in diabetes mellitus. Ann. Intern. Med., 58, 305
Ahrens, E. H., Hirsch, J., Oette, K., Farquhar J. W. and Stein, Y. (1961). Carbohydrate- induced and fat-induced lipemia. Trans. Assoc. Am. Phys., 74, 134
Bierman, E. L. and Hamlin, J. T. (1961). The hyperlipemic effect of a low-fat, high carbohydrate diet in diabetic subjects. Diabetes, 10, 432
Stone, D. B. and Connor, W. E. (1963). The prolonged effects of a low cholesterol, high carbohydrate diet upon the serum lipids in diabetic patients. Diabetes, 12, 127
Antonis, A. and Bersohn, I. (1961). The influence of diet on serum triglycerides. Lancet, 1, 3
Simpson, R. W., Mann, J. I., Eaton, J., Moore, R. A., Carter, R. and Hockaday, T. D. R. (1978). Improved glucose control in maturity-onset diabetes treated with high- carbohydrate-modified fat diet. Br. Med. J., 1, 1753
Simpson, R. W., Mann, J. I., Eaton, J., Carter, R. D. and Hockaday, T. D. R. (1979). High-carbohydrate diets and insulin-dependent diabetics. Br. Med. J., 2, 523
Brunzell, J. D., Lerner, R. L., Hazzard, W. R., Porte, D., Jr and Bierman, E. L. (1971). Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N. Engl. I. Med., 284, 521
Brunzell, J. D., Lerner, R. L., Porte, D., Jr and Bierman, E. L. (1974). Effect of a fat- free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes, 23, 138
Keen, H. and Jarrett, R. J. (1973). Macroangiopathy — its prevalence in asymptomatic diabetes. Adv. Metab. Dis., Suppl 2, 3–9
Vranic, M. and Berger, M. (1979). Exercise and diabetes mellitus. Diabetes, 28, 147
Morris, J. N., Everitt, M. G., Pollard, R. and Chave, S. P. W. (1980). Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet, 2, 1207
Lindgarde, F. and Saltin, B. (1981). Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged men. Diabetologia, 20, 134
Bern, M. M. (1978). Platelet functions in diabetes mellitus. Diabetes, 27, 342
Colwell, J. A., Lopes-Virella, M. and Halushka P. V. (1981). Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care, 4, 121
Halushka, P. V., Lurie, D. and Colwell, J. A. (1977). Increased synthesis of prostaglandin E-like material by platelets from patients with diabetes mellitus. N. Engl. J. Med., 297, 1306
Moncada, S. and Vane, J. R. (1979). Arachidonic acid metabolities and the interactions between platelets and blood-vessel walls. N. Engl. J. Med., 300, 1142
Halushka, P. V., Rogers, R. C., Loadholt, C. B. and Colwell, J. A. (1981). Increased platelet thromboxane synthesis in diabetes mellitus. J. Lab. Clin. Med., 97, 87
Ziboh, V. A., Maruta, H., Lord, J., Cagle, W. D. and Lucky, W. (1979). Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur. I. Clin. Invest., 9, 223
Betteridge, D. J., Zahavi, J., Jones, N. A. G., Shine, B., Kakkar, V. V. and Galton, D. J. (1981). Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteins. Eur. J. Clin. Invest., 11, 273
Silberbauer, K., Schernthaner, G., Sinzinger, H., Piza-Katzer, H. and Winter, M. (1979). Decreased vascular prostacyclin in juvenile-onset diabetes. N. Engl. J. Med., 300, 366
Johnson, M., Harrison, H. E., Raftery, A. T. and Elder, J. B. (1979). Vascular prostacyclin may be reduced in diabetes in man. Lancet, 1, 325
Davis, T. M. E., Bown, E., Finch, D. R., Mitchell, M. D. and Turner, R. C. (1981). In- vitro venous prostacyclin production, plasma 6-keto-prostaglandin flα concentrations, and diabetic retinopathy. Br. Med. J., 282, 1259
Davis, T. M. E., Mitchell, M. D. and Turner, R. C. (1979). Prostacyclin and thromboxane metabolites in diabetes. Lancet, 2, 789
Doliery, C. T., Friedman, L. A., Hensby, C. N. et al. (1979). Circulating prostacyclin may be deduced in diabetes. Lancet, 2, 1365
Davis, T. M. E., Mitchell, M. D., Dornan, T. L. and Turner, R. C. (1980). Plasma-6-keto- PGFlα concentrations and diabetic retinopathy. Lancet, 1, 373
Yikorkala, O., Kaila, J. and Viinikka, L. (1981). Prostacyclin and thromboxane in diabetes. Br. Med. J., 283, 1148
Ross, R. and Vogel, A. (1978). The platelet-derived growth factor. Cell, 14, 203
O’Sullivan, J. B., Cosgrove, J. and McCaughan, D. (1968). Blood sugars, vascular abnormalities and survival. The Oxford study after 17 years. Postgrad. Med. J., 44, 955
Prosnitz, L. R. and Mandell, G. L. (1967). Diabetes mellitus among Navajo and Hopi Indians: the lack of vascular complications. Am. J. Med. Sci., 253, 700
West, K. M. (1974). Diabetes in American Indians and other native populations in the New World. Diabetes, 23, 841
Ingelfinger, J. A., Bennett, P. H., Liebow, I. M. and Miller, M. (1976). Coronary heart disease in the Pima Indians. Diabetes, 25, 561
Goldstein, S., Littlefield, J. W. and Soeldner, J. S. (1969). Diabetes mellitus and aging: diminished plating efficiency of cultured human fibroblasts. Proc. Natl. Acad. Sci., 64, 155
Vracko, R. and Benditt, E. P. (1975). Restricted replicative life-span of diabetic fibroblasts in vitro: its relation to microangiopathy. Fed. Proc., 34, 68
Goldstein, S., Moerman, S. J., Soeldner, J. S., Gleason, R. E. and Barnett, D. M. (1978). Chronologic and physiologic age affect replicative lifespan of fibroblasts from diabetic, prediabetic and normal donors. Science, 199, 781
Rowe, D. W., Scarman, B. J., Fujimoto, W. J. and Williams, R. H. (1977). Abnormalities in proliferation and protein synthesis in skin fibroblast cultures from patients with diabetes mellitus. Diabetes, 26, 284
Eckel, R. H. and Fujimoto, W. Y. (1981). Insulin-stimulated glucose uptake, leucine incorporation into protein, and uridine incorporation into RNA in skin fibroblast cultures from patients with diabetes mellitus. Diabetologia, 20, 186
Schnider, S. L. and Kohn, R. R. (1981). Effects of age and diabetes mellitus on the solubility and nonenzymatic glycosylation of human skin collagen. J. Clin. Invest., 67, 1630
Howard, B. V., Fields, R. M., Mott, D. M., Savage, P. J., Nagulesparan, M. and Bennett, P. H. (1980). Diabetes and cell growth — lack of differences in growth characteristics of fibroblasts from diabetic and non-diabetic Pima Indians. Diabetes, 29, 119
Chait, A., Bierman, E. L. and Albers, J. J. (1979). Low density lipoprotein receptor activity in fibroblasts cultured from diabetic donors. Diabetes, 28, 914
Goldstein, S. (1971). Analytical review: the pathogenesis of diabetes mellitus and its relationship to biological aging. Humangenetik (Berlin), 12, 83
Stout, R. W. (1981). Atherosclerosis and the metabolism of the arterial wall. In Caird, F. I. and Grimley Evans, J. (eds.) Advanced Geriatric Medicin., Vol. 1, pp. 141–51. (London: Pitman)
Stearns, S., Schlesinger, M. J. and Rudy, A. (1947). Incidence and clinical significance of coronary artery disease in diabetes mellitus. Arch. Intern. Med., 80, 463
Breithaupt, D. J. and Leckie, R. B. (1961). Diabetes mellitus: a study of the practicability of life insurance. Can. Med. Assoc. J., 85, 299
Ricketts, H. T. (1955). The problem of degenerative vascular disease in diabetes. Am. J. Med., 19, 933
Bradley, R. F. and Bryfogle, J. W. (1956). Survival of diabetic patients after myocardial infarction. Am. 1. Med., 20, 207
Liebow, I. M., Hellerstein, H. K. and Miller, M. (1955). Arteriosclerotic heart disease in diabetes mellitus. A clinical study of 383 patients. Am. I. Med., 18, 438
Pyke, D. A. (1968). Coronary disease and diabetes. Postgrad. Med. J., 44 (Suppl.), 966
Downie, E. and Martin, F. I. R. (1959). Vascular disease in juvenile diabetic patients of long duration. Diabetes, 8, 383
New, M. I., Roberts, T. N., Bierman, E. L. and Reader, G. G. (1963). The significance of blood lipid alterations in diabetes mellitus. Diabetes, 12, 208
Krolewski, A. S., Czyzyk, A., Janeczko, D. and Kopczynski, J. (1977). Mortality from cardiovascular disease among diabetics. Diabetologia, 13, 345
Kessler, I. I. (1971). Mortality experience of diabetic patients. Twenty-six year follow-up study. Am. J. Med., 51, 715
Beach, K. W., Brunzell, J. D., Conquest, L. L. and Strandness, D. E. (1979). The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and noninsulin-dependent diabetes. Diabetes, 28, 836
University Group Diabetes Program (1970). A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. I. Design, methods and baseline results. Diabetes, 19 (suppl. 2), 747
University Group Diabetes Program (1970). A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes, 19 (suppl. 2), 789
University Group Diabetes Program (1971). Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenformin results. J. Am. Med. Assoc., 217, 777
University Group Diabetes Program (1975). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of phenformin therapy. Diabetes, 24 (suppl. 1), 65
Feisntein, A. R. (1971). Clinical biostatistics. VIII. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin. Pharmacol. Ther., 12, 167
Keen, H., Jarrett, R. J., Ward, J. D. and Fuller, J. H. (1973). Borderline diabetics and their response to tolbutamide. Adv. Metab. Dis., suppl. 2, 521
Paasikivi, J. (1973). Long-term treatment of patients with abnormal intravenous glucose tolerance after myocardial infarction. Adv. Metab. Dis., suppl. 2, 533
Tzagournis, M. and Reynertson, R. (1972). Mortality from coronary heart disease during phenformin therapy. Ann. Intern. Med., 76, 587
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1982 R. W. Stout
About this chapter
Cite this chapter
Stout, R.W. (1982). Risk factors for atherosclerosis in diabetes. In: Hormones and Atherosclerosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6264-7_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-6264-7_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6266-1
Online ISBN: 978-94-011-6264-7
eBook Packages: Springer Book Archive